Cookies: We use cookies to improve your experience on our website. By using our website, you agree to our use of cookies.

IoT Medical Devices Market Outlook Report: Latest Trends and Growth Opportunities by Region

Published On: Jul, 2024
|
Pages: 151

"The Global IoT Medical Devices Market Size was valued at USD 97.6 billion in 2024 and is projected to reach USD 117.5 billion in 2025. Worldwide sales of IoT Medical Devices are expected to grow at a significant CAGR of 23.8%, reaching USD 834.1 billion by the end of the forecast period in 2034."

"The IoT Medical Devices Market is estimated to be USD 181.73 billion in 2024. Furthermore, the market is expected to grow to USD 811.8 billion by 2031, with a Compound Annual Growth Rate (CAGR) of 23.84%."

IoT Medical Devices Market Overview

The IoT medical devices market is experiencing rapid growth, driven by the increasing adoption of technology in healthcare and the rising demand for real-time disease management. IoT medical devices, which include wearables like fitness bands, continuous glucose monitors, and connected inhalers, leverage internet connectivity to transmit medical data, allowing for more personalized and efficient patient care. These devices are pivotal in remote monitoring, chronic disease management, and preventive healthcare, contributing to better patient outcomes and reducing healthcare delivery costs. As healthcare systems worldwide shift towards more patient-centric models, IoT medical devices are becoming indispensable tools for both providers and patients, ensuring continuous care and monitoring without the constant need for physical hospital visits.

Further driving the market's expansion is the integration of advanced technologies such as AI and machine learning, which enhance the functionality of IoT devices by enabling sophisticated data analysis and predictive diagnostics. This integration facilitates early detection of potential health issues, personalized treatment plans, and improved management of chronic diseases. The convergence of healthcare and technology through IoT devices also supports the growing trend of home healthcare, which is particularly beneficial for elderly populations and patients with chronic conditions, promoting independence and improving their quality of life.

Latest Trends

One of the prominent trends in the IoT medical devices market is the increasing integration of AI to provide more precise diagnostics and treatment options. AI algorithms can analyze data collected by IoT devices to detect anomalies that may indicate health issues before they become severe, thereby offering a proactive approach to healthcare. Additionally, there is a growing emphasis on patient-centered technology, which includes the development of user-friendly devices that can be easily managed by patients at home, improving patient engagement and adherence to treatment protocols. Another significant trend is the enhancement of data security in IoT devices, addressing one of the major concerns associated with their adoption. Advanced encryption methods and secure data transmission protocols are being implemented to protect sensitive patient information from cyber threats.

Drivers

The primary drivers of the IoT medical devices market include the aging global population and the increasing prevalence of chronic diseases, which necessitate continuous monitoring and long-term healthcare strategies. IoT devices play a crucial role in managing health conditions from home, reducing the need for frequent hospital visits and thereby decreasing healthcare costs. Technological advancements in connectivity and the widespread availability of high-speed internet also contribute to the market's growth, making it feasible to transmit large amounts of health data in real time. Furthermore, government initiatives promoting digital health solutions and the adoption of electronic health records (EHRs) encourage the integration of IoT devices within the healthcare infrastructure, enhancing the efficiency of healthcare delivery and patient outcomes.

Market Challenges

Despite the vast potential and rapid growth of the IoT medical devices market, several challenges remain. High costs associated with the development and deployment of advanced IoT medical devices can hinder their widespread adoption, particularly in developing regions where healthcare budgets are limited. Data privacy and security concerns also pose significant challenges, as the increase in device connectivity raises the risk of data breaches and cyber attacks. Ensuring interoperability among various devices and systems within the healthcare ecosystem is another hurdle, as it requires standardization of protocols and technologies. Additionally, there is a need for regulatory compliance with stringent standards, which can delay the introduction of new innovations in the market.

Major Players in the IoT Medical Devices Market


1. Medtronic PLC
2. Philips Healthcare
3. GE Healthcare
4. Siemens Healthineers
5. Boston Scientific Corporation
6. Johnson & Johnson Services, Inc.
7. Biotronik
8. Omron Healthcare, Inc.
9. BioTelemetry, Inc.
10. Honeywell Life Care Solutions
11. AgaMatrix, Inc.
12. iHealth Labs Inc.
13. Abbott Laboratories
14. AliveCor, Inc.
15. Garmin Ltd.

Market Segmentation


  • By Product Type:
  • Wearable External Devices
  • Implanted Medical Devices
  • Stationary Medical Devices
  • By Application:
  • Diagnosis & Treatment
  • Monitoring
  • Others
  • By End User:
  • Hospitals & Clinics
  • Homecare
  • Others
  • By Region:
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Please fill in the form to receive the detailed Table of Contents

Get Free Sample

At OG Analysis, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.

Start Now! Please fill the form below for your free sample.

Why Request a Free Sample?

Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.

Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.

Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.

Embark on your journey towards strategic decision-making by requesting a free sample from OG Analysis. Experience the caliber of insights that can transform the way you approach your business challenges.

You can purchase individual sections of this report. Explore pricing options for specific sections.

FAQ's

The Global IoT Medical Devices Market is estimated to generate USD xxx.x million in revenue in 2048

The Global IoT Medical Devices Market is expected to grow at a Compound Annual Growth Rate (CAGR) of x.xx% during the forecast period from 2024 to 2031.

By 2031, the IoT Medical Devices Market is estimated to account for USD xxx.x million

License

Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM

Need something within your budget? NO WORRIES! WE GOT YOU COVERED!

Reach Out to Us
phone_icon

+91 888 64 99099

phone_icon

sales@oganalysis.com

Related Products

Bioinformatics Market Outlook Report: Latest Trends and Growth Opportunities by Region

"The Global Bioinformatics Market Size was valued at USD 15.6 billion in 2024 and is projected to reach USD 17.3 billion in 2025. Worldwide sales of Bioinformatics are expected to grow at a significant CAGR of 12.3%, reaching USD 50.5 billion by the end of the forecast period in 2034." Bioinformatics Market Overview The bioinformatics market is experiencing rapid expansion, driven by the integration of information technology and complex biological data. Bioinformatics encompasses the development and use of computational tools and approaches for expanding the use of biological, medical, behavioral, or health data. The increasing demand for nucleic acid and protein sequencing due to developments in sequencing technologies and the rising prevalence of chronic diseases necessitating new drug discoveries are fueling market growth. Furthermore, the vast volumes of genomic data generated by high-throughput technologies have underscored the necessity for bioinformatics expertise to analyze and interpret data effectively. Additionally, bioinformatics is crucial in the fields of molecular medicine, personalized medicine, and preventive medicine. As biotechnology and pharmaceutical companies continue to invest in genomics and proteomics research, the demand for bioinformatics solutions to manage large datasets effectively is expected to grow. The market is also supported by the increasing use of bioinformatics in agriculture for crop improvement and in veterinary science to maintain animal health. With governments across the globe recognizing the potential of bioinformatics in healthcare innovation, funding and support for research in this field are increasing, further propelling the market forward. Latest Trends A significant trend in the bioinformatics market is the rising adoption of cloud-based bioinformatics solutions, which offer scalable and flexible data storage capabilities. Cloud computing facilitates efficient data management and analysis of large-scale biological data, enabling researchers and scientists to access bioinformatics tools and databases remotely. Another trend is the growing integration of artificial intelligence (AI) and machine learning (ML) in bioinformatics, which enhances the capabilities of genomic and proteomic analysis. AI and ML algorithms are being increasingly utilized to predict disease associations with specific biomarkers and to accelerate drug discovery processes by identifying potential drug targets more efficiently. Drivers The primary drivers of the bioinformatics market include the surging demand for genomic and proteomic research. The advancements in genomic sequencing technologies have drastically reduced the cost of sequencing while increasing the speed, thus generating enormous amounts of data that require analysis. The integration of bioinformatics in disease diagnostics is another key driver. Bioinformatics tools are critical in identifying genetic markers and understanding the genetic bases of diseases, which is pivotal in developing targeted therapies. Additionally, the expanding applications of bioinformatics in drug discovery and development to understand protein interactions and gene sequencing further stimulate the market’s growth. Market Challenges Despite the dynamic growth, the bioinformatics market faces several challenges. One major challenge is the complexity of biological data, which requires sophisticated tools for accurate analysis and interpretation. There is also a significant skill gap, as the interpretation of bioinformatics data demands a high level of expertise in both biology and computer science. Furthermore, data security and privacy concerns are increasingly prominent, as the handling of sensitive genetic data poses ethical and legal challenges. The lack of standardized formats for data integration and the interoperability issues between various data formats and software also hinder the effective use of bioinformatics resources. Major Players in the Bioinformatics Market 1. Thermo Fisher Scientific Inc. 2. Illumina Inc. 3. QIAGEN 4. Agilent Technologies 5. Bio-Rad Laboratories 6. Roche Sequencing 7. PerkinElmer Inc. 8. BGI Genomics 9. Eurofins Scientific 10. Waters Corporation 11. SOPHiA GENETICS 12. Partek Incorporated 13. DNASTAR 14. Biomax Informatics AG 15. PierianDx

Published:Jul-2024
Phytochemical & Plant Extracts Dietary Supplements Market Outlook Report

"The Phytochemical & Plant Extracts Dietary Supplements Market is estimated at USD 1,345 million in 2023. Further, the market is expected to grow from USD 1,411 million in 2024to USD 2,071 million in 2031at a CAGR of 5.6%. Phytochemical & Plant Extracts Dietary Supplements Market Market Overview Dietary Supplements (DS) are products like vitamins, minerals, herbs, amino acids, enzymes, and others that are added to a diet to complete dietary needs or to make up for a nutrition deficiency. Dietary supplement dosage forms include pills, capsules, powders, drinks, energy bars, and others. Supplement use can also be considered complementary or alternative medicine. It is important to remember that supplements are not required to undergo the same stringent testing as OTC and prescribed medicine and are not regulated as closely by the Food and Drug Administration (FDA). Phytochemical and plant extract dietary supplements are the most common dietary supplement used by adults and children across the globe. Despite the popularity of supplements, many individuals can obtain all the required vitamins and minerals through a healthy diet alone. Healthy individuals who take vitamin or dietary supplements need to limit the potency to 100% or less of the dietary reference intake for their age, gender, and life stage. Consuming a supplement that contains no more than 100% of the Daily Value (DV) is usually considered safe. Latest Trends in Phytochemical & Plant Extracts Dietary Supplements Market Rising Trend Of Veganism & Increasing Popularity Of Plant-Based Supplements: With the vegan lifestyle becoming increasingly popular, the demand for supplements preventing nutritional deficiencies when adopting a vegan diet and vegan versions of dietary supplements is set to increase in recent times. Veganism is an increasing trend in established markets such as North America and Europe. The emerging economies in Asia & Pacific are also experiencing the rising trend of plant-based diets. With growing awareness regarding health and nutrition, more people are opting for plant-based products, thus, increasing the popularity of plant-based protein supplements. Driving Factors Growing Ageing Population & Increasing Prevalence Of Chronic Diseases: The growing aging population is one of the major factors driving the market growth during the forecast period. People over 50 may need more dietary supplements than younger adults. Over 75% of adults take dietary supplements such as probiotics, curcumin, vitamin D, fish oil, and multivitamin and mineral supplements. The growth in the proportion of the senior population is a global phenomenon. By 2030, globally, 1 in 6 people will be aged 60 years or above and reach 1.4 billion from 1 billion in 2020. By 2050, the world's aging population of 60 years and older will double. People aged 80 years or older are estimated to triple between 2020 and 2050 to reach 426 million. Chronic diseases kill 41 million people each year, equivalent to 74% of all deaths worldwide. Each year, 17 million people die from an NCD before age 70; 86% of these premature deaths occur in low- and middle-income countries. An unhealthy diet, mixed with a sedentary lifestyle, tobacco usage, lack of physical activity, or excessive alcohol consumption, increases the probability of people developing chronic conditions. A variety of nutrients, vitamins and minerals is needed per day to stay healthy and, most importantly, to preserve a healthy system that prevents chronic diseases. Market Challenges High Cost Of Dietary Supplements & High Cost Of Clinical Trials: The dietary supplement demand is estimated to rise due to consumers placing more emphasis on self-care than ever before. The factors that affect the pricing of dietary supplements include dose form, raw materials, ingredient sources, supplement packaging, testing and certification. The price of a dietary supplement might vary significantly based on the ingredients' origin (synthetic or natural) and seasonality. Sports dietary supplements are considered premium nutrition-rich dietary supplements due to their ingredients and nutritional content. Sports dietary supplements are not cost-effective, due to which demand for sports supplements may be affected. Technology and science advancements are helping people by providing supplements to help people with different problems. But due to their costly nature, not all people can afford them, especially in underdeveloped regions. Without patent protection, the key players face price pressure from competitors and cannot obtain enough profits from high product prices to pay for the costs of large phase trials. Despite the numerous trials launched, the FDA has not approved any dietary supplement or food to prevent cancer, halt its growth, or prevent its recurrence. Companies Mentioned Creative Bioscience Glanbia Plc Charles Bowman &Company Iovate Health Sciences International Inc., Amway Koninklijke DSM N.V.

Published:Feb-2024
Biometrics As a Service in Healthcare Market Outlook Report: Latest Trends and Growth Opportunities by Region

"The Biometrics As a Service in Healthcare Market is estimated to be USD 627.3 million in 2024. Furthermore, the market is expected to grow to USD 1839.2 million by 2031, with a Compound Annual Growth Rate (CAGR) of 16.61%." Biometrics as a Service in Healthcare Market Overview The Biometrics as a Service (BaaS) in healthcare market is witnessing rapid growth due to the increasing need for secure and efficient patient identification systems and healthcare fraud prevention. BaaS integrates various biometric technologies, such as fingerprint scanning, facial recognition, and iris recognition, to provide secure access to medical records and healthcare services. The healthcare sector faces unique challenges in protecting sensitive patient data and ensuring compliance with stringent regulatory requirements like HIPAA in the U.S., which drives the demand for robust biometric solutions. This technology not only enhances security but also improves patient experience by streamlining the identification process, reducing wait times, and minimizing administrative errors. In the current digital age, healthcare providers are increasingly adopting cloud-based solutions to manage vast amounts of health data efficiently. Biometrics as a Service, hosted on cloud platforms, offers scalability, flexibility, and cost-effectiveness, making advanced biometric technologies accessible to a broader range of healthcare organizations. As BaaS solutions continue to evolve, they are becoming an integral part of telemedicine, remote patient monitoring, and mobile health applications, where verifying the identity of users is crucial to ensure the confidentiality and integrity of health information exchanged. Latest Trends One of the prominent trends in the Biometrics as a Service in healthcare market is the integration of artificial intelligence (AI) with biometric technologies. AI enhances the accuracy and efficiency of biometric systems by enabling sophisticated algorithms that can analyze complex biometric data in real time. Another emerging trend is the use of behavioral biometrics, which goes beyond physical characteristics to include patterns of behavior such as keystroke dynamics, gait analysis, and voice recognition. This trend is gaining traction as it offers a layer of security that is difficult to replicate or steal, providing a more nuanced approach to patient and healthcare provider verification. Drivers The primary drivers of the Biometrics as a Service in healthcare market include the growing incidences of data breaches and medical identity theft, which have heightened the need for secure patient identification and access control systems. The increasing digitalization of healthcare records and the expansion of telehealth services amid the COVID-19 pandemic have further underscored the importance of reliable authentication methods. Additionally, the global push towards enhancing patient experience and operational efficiency in healthcare settings encourages the adoption of biometric technologies. Governments and health organizations are also implementing stricter regulations regarding patient data security, propelling the demand for compliant biometric solutions. Market Challenges Despite the significant advantages, the adoption of Biometrics as a Service in healthcare faces several challenges. High deployment costs and complexity in integrating biometric systems with existing healthcare IT infrastructure are major hurdles for many organizations. There are also concerns about privacy and the ethical use of biometric data, as mishandling can lead to severe privacy violations. Technical limitations, such as inaccuracies in biometric data capture and susceptibility to spoofing attacks, pose additional challenges. Moreover, there is a need for ongoing maintenance and updates to ensure the effectiveness of biometric systems, which can be a resource-intensive process for healthcare providers. Major Players in the Biometrics as a Service in Healthcare Market 1. NEC Corporation 2. Aware, Inc. 3. Fujitsu Limited 4. Thales Group 5. Leidos 6. M2SYS Technology 7. Bio-Key International 8. Imageware Systems Inc. 9. Iritech Inc. 10. Veridium Ltd. 11. Precise Biometrics 12. Suprema HQ Inc. 13. Crossmatch Technologies 14. OT-Morpho 15. HID Global Corporation

Published:Jul-2024
Resources
Company
Sign up for Offers & Promotions
Company Logo
Copyright © 2025 OG Analysis Limited. All Rights Reserved.

Designed and Developed by Aurora e-Labs